Business Type:Trading Company
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
CAS NO.114-07-8
Enterprise Standard(1-10)GramEnterprise Standard(11-100)Gram
Pharma grade 85% Antibacterial pharmaceutical powder Erythromycin
Product Name |
Erythromycin |
Synonyms |
abboticin;abomacetin;dotycin; |
CAS |
114-07-8 |
MF |
C37H67NO13 |
MW |
733.93 |
EINECS |
204-040-1 |
Purity |
99% |
Appearance |
White to off white crystalline powder |
Certification |
ISO 9001, USP, BP
|
Grade |
Pharma Grade |
Usage |
For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough),as adjunct to antitoxin in infections |
Packing |
Discreet packing ways as your requirement,100% go through |
Storage |
Store in cool and dry area and keep away from direct sunlight |
Usage:
1. Erythromycin can affect protein synthesis of bacteria, the general effective against gram positive bacteria, mainly used for the treatment of G caused by penicillin resistant Staphylococcus aureus infection.
2. Erythromycin is macrolide antibiotics commonly used, antibacterial spectrum similarity with penicillin, mainly used for patients allergic to penicillin, or of penicillin resistant Staphylococcus aureus infection, can also be used for Streptococcus, pneumococcus infection and diphtheria carrier.
3. This is the large ring lactone class antibiotic derivatives intermediates of bacteriostatic antibiotics, antibacterial spectrum was similar to green bacteria.
Specification:
Item | Specification | Result |
Appearance |
White or almostwhite crystalline powder |
Conform |
Identification | The reaction is postitive | Positive Reaction |
PH | 6.0-8.0 | 6.13 |
Heavy Metals | ≤20ppm | <20ppm |
Arsenic | ≤2ppm | <2ppm |
Loss on drying | ≤6.0% | 5.4% |
Residue on ignition | ≤1.0% | 0.07% |
Assay | ≥750μ/mg | 838μ/m |
Description:
Erythromycin is a 14-membered macrocyclic lactone with broad spectrum antibiotic activity,isolated from
Saccharopolyspora erythraea (formerly Streptomyces erythreus) in 1952.Erythromycin is one of only a handful of
microbial metabolites to have profoundly shaped the treatment of bacterial disease in the last 50 years.
Erythromycin has given rise to new generations of semi-synthetic derivatives with improved stability and
potency.Our product has been HPLC-purified to remove contaminants and degradation products.